摘要
目的研究采用胰岛素泵持续皮下注射赖脯胰岛素的方式对初诊糖尿病患者进行治疗的效果,以便为临床的干预工作提供可行依据。方法将2017年6月至2018年11月到我院治疗的78例初诊糖尿病患者随机分为观察组和对照组,均39例。分别为患者通过常规胰岛素治疗(对照组)和胰岛素泵皮下持续注射赖脯胰岛素治疗(观察组),比较治疗效果。结果观察组的血糖控制有效率(36例,占92.31%)明显高于对照组(27例,占69.23%),P<0.05;观察组低血糖事件发生率(4例,占10.26%)低于对照组(10例,占25.64%),P<0.05;治疗后观察组的胰岛素日用量和患者血糖达标时间都比对照组更优,P<0.05。结论临床对初诊糖尿病患者治疗的过程中应注意控制患者的血糖状况,避免患者出现低血糖情况,为患者采用胰岛素泵持续皮下输入赖脯胰岛素的方式进行治疗能有效的帮助患者提升治疗的效果,并且具有较好的安全性。
Objective To study the effect of insulin pump continuous subcutaneous injection of insulin lispro on the treatment of newly diagnosed diabetic patients, so as to provide a feasible basis for clinical intervention. Methods Seventy-eight newly diagnosed diabetic patients who came to our hospital for treatment from June 2017 to November 2018 were randomly divided into observation group and control group, with 39 cases in each group. The patients were treated with conventional insulin therapy(control group) and insulin pump subcutaneous continuous injection of insulin lispro(observation group) to compare the therapeutic effects. Results The effective rate of blood glucose control in the observation group(36 cases, accounting for 92.31%) was significantly higher than that of the control group(27 cases, accounting for 69.23%), P<0.05;the incidence of hypoglycemia events in the observation group(4 cases, accounting for 10.26%), it was lower than the control group(10 cases, 25.64%), P<0.05;after treatment, the daily insulin dosage and the patient’s blood glucose reaching time in the observation group were better than the control group, P<0.05. Conclusion Clinical treatment of newly diagnosed diabetic patients with continuous subcutaneous infusion of insulin lispro with insulin pump can effectively help patients to improve the treatment effect, and has good safety.
作者
王作华
WANG Zuohua(Central Hospital of Yingkou Economic and Technological Development Zone,the Sixth People's Hospital of Yingkou City,Yingkou 115007,China)
出处
《中国医药指南》
2021年第5期42-43,共2页
Guide of China Medicine
关键词
糖尿病
胰岛素泵
持续皮下注射胰岛素
初诊
Diabets
Insulin pump
Continuous subcutaneous injection of insulin
Newly diagnosed
